Background Cardiovascular disease, which includes coronary artery disease, stroke and
peripheral vascular disease, is a leading cause of death worldwide. Homocysteine is an …

Coronary slow flow (CSF) is an angiographic phenomenon with specific epidemiologic
characteristics, associated clinical presentation, and prognosis. Although patients with CSF …

Coronary slow flow (CSF) phenomenon, also known as cardiac syndrome Y, is defined as
the delayed opacification of the coronary vasculature at the distal level. Different hypotheses …

Background Systemic immune-inflammation index (SII, platelet× neutrophil/lymphocyte
ratio), a new marker of inflammation, is associated with adverse cardiovascular events, but …

INTRODUCTION: The expression “slow coronary flow phenomenon”(SCFP) indicates a slow
progression of the contrast seen at the coronary angiography in the absence of epicardial …

Background The coronary slow flow phenomenon (CSFP) is an angiographic finding
characterized by delayed distal vessel opacification in the absence of significant epicardial …

The coronary slow flow phenomenon (CSFP) is associated with coronary microvascular
dysfunction although the responsible mechanisms are unknown. This study compared …

Background: The slow coronary flow (SCF) phenomenon is a coronary microvascular
disorder characterized by the delayed passage of contrast in the absence of obstructive …

Current theories state that Alzheimer's disease (AD) is a vascular disorder that initiates its
pathology through cerebral microvascular abnormalities. Endothelial dysfunction caused by …

The coronary slow flow phenomenon (CSFP) is a disease entity characterized by slow
progression of angiographic contrast in the coronary arteries in the absence of stenosis in …